3 latest FDA approvals

Here are the three latest drugs or medical devices approved by the FDA this week.

Advertisement

1. Imfinzi is used to treat patients with inoperable, midstage non-small cell lung cancer that has not metastasized throughout the body.

2. Osmolex may be used to treat patients with Parkinson’s disease or drug-induced movement disorders.

3. The Trevo Retriever, a clot-removal device, may now be used as a first-line treatment for stroke patients for up to 24 hours after symptom onset. 

More articles on supply chain:
Pharma deals in an era of heightened competition: 6 recent drugmaker transactions, partnerships
Recognize 5 types of supply chain leaders in your hospital
Merck to purchase Viralytics for $394M: 3 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.